Molecular Partners Ag (MOLN) Payables (2020 - 2026)

Molecular Partners Ag (MOLN) has reported Payables for 7 consecutive years, with $202438.3 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Payables rose 4.75% year-over-year to $202438.3 in Q2 2026; TTM through Jun 2026 was $202438.3, a 4.75% increase from a year earlier, with the FY2025 full-year figure at $192980.6, changed N/A from the prior year.
• Payables was $202438.3 for Q2 2026 at Molecular Partners Ag, down from $204320.7 in the prior quarter.
• Over five years, Payables peaked at $5.8 million in Q2 2022 and troughed at $177960.1 in Q1 2025.
• A 5-year average of $2.2 million and a median of $2.4 million in 2023 frame the typical range for Payables.
• Across the five-year window, Payables rose 18.94% in 2024 and plunged 95.16% in 2025, its largest moves.
• Over 5 years, Payables stood at $2.2 million in 2022, then plunged by 32.7% to $1.5 million in 2023, then surged by 83.64% to $2.7 million in 2024, then sank by 92.72% to $200187.2 in 2025, then increased by 1.12% to $202438.3 in 2026.
• The last three Payables figures came in at $202438.3 (Q2 2026), $204320.7 (Q1 2026), and $200187.2 (Q4 2025), per Business Quant data.